Verbatim response from Perplexity
Several compounded GLP-1 providers say they use licensed U.S. pharmacies, but the exact pharmacy type matters: state-licensed 503A pharmacies are still used for certain patient-specific compounded products, while 503B outsourcing facilities are federally registered and also licensed/regulated in the U.S.[2][4]
Providers from your results that explicitly reference U.S.-licensed pharmacy fulfillment include:
- Empower Pharmacy — it says it is a PCAB-accredited compounding pharmacy, is licensed to ship nationwide, and offers compounded semaglutide and tirzepatide injections.[1]
- Henry Meds — it says it fills compounded semaglutide and tirzepatide through licensed pharmacies, and the result notes partner pharmacies including Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx.[6]
- Fridays — the result says it delivers from 503A and 503B certified compounding pharmacies, though it does not name every partner publicly.[6]
- Schaffner Pharmacy — it states its products are made by FDA-certified 503B compounding pharmacies.[9]
- Policy Lab’s referenced provider network — it says compounded semaglutide is fulfilled through Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx, all described as licensed compounding pharmacies.[6]
A few important caveats:
- The FDA says compounded drugs are not FDA approved, and compounders must meet specific conditions to qualify for legal exemptions.[2][3]
- For GLP-1s, legality has narrowed as shortages ended; some compounded versions may still be allowed only for specific medical needs or other limited circumstances.[3][5][7]
- Some marketing claims about “503A/503B” may be broader than what is currently permitted for a specific GLP-1 ingredient, so it is worth confirming the exact dispensing pharmacy for your prescription.[6]
If you want, I can turn this into a short comparison table of providers, their pharmacy type, and whether they disclose the exact U.S. pharmacy partner.